Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
E

Failure to Monitor Anticoagulant Side Effects as Directed in Care Plans

West Allis, Wisconsin Survey Completed on 05-01-2025

Penalty

Fine: $145,850
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that each resident’s drug regimen was free from unnecessary drugs by not providing appropriate monitoring for residents prescribed Eliquis, an anticoagulant. Four residents were identified as receiving Eliquis without documented monitoring for side effects such as bleeding or bruising, despite care plans indicating that such monitoring should occur at least daily. The care plans for these residents specifically included interventions to monitor for signs of active bleeding, but there was no evidence in the medical records, Medication Administration Records (MARs), or Treatment Administration Records (TARs) that this monitoring was being performed or documented. Interviews with facility staff revealed that the transition to a new electronic charting system resulted in the removal of prompts or reminders for staff to monitor for medication side effects. Certified Nursing Assistants (CNAs) and nursing staff reported that previous printed materials, which included monitoring instructions, were no longer available after the system change. Staff members, including LPNs and RN supervisors, acknowledged that monitoring for bleeding should be in place for residents on blood thinners, but confirmed that such monitoring was not being documented or ordered in the current system. The Director of Nursing (DON) and Director of Clinical Operations stated that monitoring information was only present in the care plan and not in active orders or documentation, and believed that documentation was not required beyond the care plan. Additionally, the facility did not have a policy for anticoagulation or high-risk medication monitoring. The Director of Clinical Operations stated that the pharmacy advised monitoring was not necessary for Eliquis, and that it was sufficient for the information to be in the care plan. However, surveyors clarified that daily monitoring should be documented as indicated in the care plans. Despite being informed of the lack of monitoring documentation, facility leadership did not provide further explanation or evidence that monitoring was occurring for the affected residents.

An unhandled error has occurred. Reload 🗙